Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · ULTRALIFE CORP (ULBI)

Ultralife Q3 sales rise 11.3% to $48.3 million; pending $320 million EnerSys deal

Positive Impact 5 of 5 m&a

Ultralife reported third-quarter 2026 sales of $48.3 million, up 11.3% from a year earlier, with GAAP net income of $2.4 million, or $0.14 per share, compared with a loss of $0.07 per share in the 2025 quarter. The company had already agreed on October 27, 2026 to be acquired by EnerSys in an all-cash transaction valued at approximately $320 million, which is expected to close in the first quarter of 2027, so Ultralife will not hold a conference call on the results.

Key points

  • Q3 2026 sales of $48.3 million vs. $43.4 million in Q3 2025; gross margin 27.5% vs. 22.2%
  • Operating income of $3.2 million vs. an operating loss of $1.0 million a year earlier; GAAP EPS $0.14 vs. ($0.07)
  • Backlog of $136.0 million at quarter end, up from $117.5 million at the end of Q2 2026
  • All-cash acquisition by EnerSys (NYSE: ENS) valued at approximately $320 million, including assumed net debt; expected close in Q1 2027

The filing

CompanyULTRALIFE CORP (ULBI)
Form8-K, current report
Filed with the SECNov 9, 2026, 3:37 PM ET
Accession number0001437749-26-035865

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 3:51 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.